Nicotine Lozenge Bioequivalence Study

Completed · Phase 1

Conditions studied: Smoking Cessation

In brief

To compare the bio equivalence of new nicotine lozenge formulation with the reference nicotine lozenge so as to deliver the same nicotine blood profile.

Key facts

Study ID

NCT01536704

Run by

GlaxoSmithKline

People needed

50

Starts

2011-07-01

Expected to finish

2011-08-01

Last updated by the study team

2013-04-26

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants must be healthy smokers who usually smoked their first cigarette within 30 minutes of waking.
• Body Mass Index within the range 19-27 kilograms/meters\^2

You may not qualify if…

• Participants who used chewing tobacco or tobacco products other than cigarettes within 21 days of screening visit

Where it is running

• Celerion NEBRASKA — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.